R&G PharmaStudies

R&G PharmaStudies, founded in 2008, operates as a specialized Contract Research Organization (CRO) providing comprehensive clinical research outsourcing services. The firm supports global pharmaceutical and medical device enterprises, as well as research institutions, by delivering end-to-end data management and clinical trial solutions. Their technical service portfolio encompasses regulatory affairs, clinical pharmacology, medical affairs, statistical analysis, clinical operations, and pharmacovigilance. By maintaining a focus on high-quality data management services, the company facilitates complex R&D processes across international markets.

With a workforce of 500-1,000 employees, R&G PharmaStudies has successfully executed over 2,000 clinical trial projects. The organization maintains a robust client base exceeding 1,000 pharmaceutical R&D customers, demonstrating significant operational scale within the competitive CRO landscape. Meet R&G PharmaStudies's team to understand the leadership and operational expertise driving these large-scale clinical initiatives. Their internal structure supports specialized departments, including medical and health, legal, and human resources, ensuring compliance and operational efficiency across all project lifecycles.

The company’s market presence extends across the United States, Asia-Pacific, and domestic Chinese markets, positioning it as a key player in the global clinical research sector. R&G PharmaStudies competes with established entities such as MDS Pharma Services and Advanced Clinical, leveraging its deep expertise in clinical operations to maintain a competitive edge. By integrating advanced data management systems and rigorous regulatory compliance, the firm continues to expand its footprint in the B2B pharmaceutical services industry. Their commitment to operational excellence remains central to their strategy for supporting global drug development and medical device innovation.